100% found this document useful (6 votes)
4K views10 pages

ASCP Exam

This document provides a study guide for the January 2020 ASCP exam, outlining the main content areas and their approximate weighting. It covers Blood Bank (17-22%), Chemistry (17-22%), Hematology, Microbiology (17-22%), Urinalysis/Body Fluids (5-10%), Immunology, and Laboratory Operations (5-10%). The Blood Bank section lists 47 topics, and the Chemistry section lists 12 topics, to focus exam preparation.

Uploaded by

noone
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
100% found this document useful (6 votes)
4K views10 pages

ASCP Exam

This document provides a study guide for the January 2020 ASCP exam, outlining the main content areas and their approximate weighting. It covers Blood Bank (17-22%), Chemistry (17-22%), Hematology, Microbiology (17-22%), Urinalysis/Body Fluids (5-10%), Immunology, and Laboratory Operations (5-10%). The Blood Bank section lists 47 topics, and the Chemistry section lists 12 topics, to focus exam preparation.

Uploaded by

noone
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 10

January 2020 ASCP Exam Study Document:

BB, Chem, Heme, Micro(17-22%), UA/BF, Immuno, LabOps (5-10%)

BLOOD BANK (17-22%):


1. Adult volume  4-6L
2. TFR  any adverse event associated with TF of blood components
3. Antibodies of ABO afe unique  they are naturally occurring
4. Thawed deglycerolized, reconstituted in open system  must be used within 24hr (14days if closed)
5. First marker after exposure to HepB  HBsAg
6. Maximum WBC in leukocyte-reduced unit  5*10^6
7. Chronic transfusions  may lead to iron overload
8. Reaction at IS, variable dosage  P2 antibodies (enzymes inc activity  ABO, LIP, Rh, Kidd)
9. A2B POS  reaction at anti-A/B/D, partial reaction at A1, no reaction at B
10. Most Factor VIII concentration  cryoprecipitate
11. Reaction 5 days later than TF by Jka antibody  DHTR
12. Rejuvenation for RBC  influences the 2,3-DPG
13. Occurrences during HTR of Rh  AHG phase, Preference to double Rh, DAT+ (Rh not complement)
14. Administer RhIg  Therapeutic abortion, ectopic pregnancy, Rh+ fetus
15. Whole blood storage  temperature in 1-6C
16. Papain  Two Fab with light chain and partial heavy chain (Pepsin makes a Fab2 and Fc)
17. Post-TF, has bruising and very low platelets  PTP
18. Differentiation with Bombay and group O  done by Anti-H (Ulex europaeus)
19. FFP should be transfused within 24hrs of thawing
20. Ab/Ab  AA, BB, AB
21. For Rh- mother and Rh- fetus  check with weak D that fetus is Rh-
22. Lub  high frequency antigen!
23. AHG sera  may be Monoclonal, Polyclonal, Complement
24. Resistance to P. vivax  Those with Fy(a-b-)
25. Danger to TF patient (group O) with A blood  Patient’s anti-A destroys donor cells with consequences
26. Maximum number of WBC in 95% apheresis platelets  5*10^6
27. Which is screened only using questioning?  Malaria
28. Elder patient with no reaction on anti-A/B or A/B cells  depressed antibody production
29. Allergic reaction from RBC can be reduced  by washing the RBC
30. AB blood  not anti-A/B
31. P-value for 95% by antibody ID  3 rule ins, 3 rule outs
32. Phenotype  expression of traits
33. Acute intravascular hemolysis most associated with  TF of ABO RBC
34. When notified that donor unit tests positive for disease  look back
35. Universal donor  Group O
36. HDFN/HTR/AIHA from ab/complement to RBC  In vivo sterilization
37. For Ab screening, phase of most importance of reactivity  AHG
38. Vials of RhIg = volume of fetal blood /30mL
39. Most common infective agent through TF that results on morbidity/mortality  bacteria
40. Most associated with anti-I  CAD
41. Antibody found in virtually all sera  anti-I
42. Infant vs adult antigen  i decreases as a person matures, and I increases through adulthood
43. Most implicated in bacterial contamination  platelets
44. In newborns with reaction to Anti-A,B and NT with RBC  AB typed
45. Platelet concentrates  must maintain a pH of 6.2 or above
46. Most common type of AIHA  WAIHA
47. Non-invasive method to predict anemia in fetus  Color Doppler MCA-PSV
48. RBC gains most of its energy by  glycolytic pathways
49. Most likely to cause circulatory overlead  whole blood
50. RBC units with CDPA-1  can be stored at 35 ( 21 for CPD, 42 for AS)
51. DHTR  caused by antibodies against Kidd
52. A2 vs A1  A2 antigens are linear whereas A1 antigens are branched
53. Person that lived in the UK from 1980-1996 for 3+ months permanently deferred  from CJD/vCJD
54. AHTR based into categories  Fever, Allergic, Pulmonary involvement ( not liver failure)
55. Rejuvenation can be used  up to 3 days post-expiration date
56. Recommended by FDA to replace HIV-1 p24  HIV-1 NAT (Anti-HIV1/2 still required)
57. Basic technique to detect unexpected antibodies with reagent cells  IAT
58. Shelf life with blood and CPDA-1  35 days
59. Biggest concern for newborn infant suffering from HDFN  accumulation of bilirubin
60. Used to determine paternity  HLA
61. Question on Weiner/Fisher-Race (R0/1/2/z, r/’/”/y)
62. Control system from AHG tests  IgG sensitized red cells
63. Indications of anemia  pulse>100bpm, >30breaths/min, Hb<7g/dL
64. Offspring of AA/BB  AB
65. TRALI characterized by  respiratory distress, pulmonary edema, acute onset
66. Primary Ab response  takes about 5-10 days
67. Former patient with anti-E 4 years ago, but no longer detected  still crossmatch E negative units
68. HDFN does not occur with  mom and dad both Rh-negative
69. Ab that can agglutinate RBC in AHG phase  IgG
70. Patient with TF history of 3 units is DAT+ with IgG specificity. To ID phenotype  PCR-assay
71. Common characteristic of anti-Jka/Jkb  shows dosage
72. Positive reaction of CC after a negative AHG  validates reaction
73. Most severe type of of HTR  Anti-A, B, AB
74. Leukocyte-reduced blood product used to reduce febrile reactions  and CMV
75. Screen for FMH indicated for  weak D+ infant, D+ infant, D-negative mom
76. M. pneumoniae infections  anti-I
77. In type A blood  Anti-B
78. IS of IAT  detects clinically insignificant cold antibodies
79. Section of Ig responsible for classes  heavy chains
80. Rejuvenated blood  must be washed before administration
81. Patient sample for compatibility testing  72 hours
82. Bombay  Two h at H locus
83. 300uG of RhIg  30mL of fetal WB
84. To detect Ab on newborn RBC  perform DAT on cord blood
85. RhIg in postpartum  Passive protection
86. Bombay can’t receive Type O  due to anti-H
87. TFR work up  perform clerical check, hemolysis/icterus, pre/post TF specimens
88. RhIg  used for Rh- moms and Rh+ baby
89. HDFN monitoring and intrauterine transfusions  cordocentesis
90. Platelet refractoriness/poor response  perform HLA typing for therapeutic effect
91. Platelet antigen most encountered  HPA-1a
92. FNHTR patients should receive blood components  that are leukoreduced
93. In an emergency  give Type O, Rh negative
94. Frozen RBC can be stored for 10 years  at -65C or lower
95. Transfusion associated GVH disease  caused by lymphocytes
96. Storage of RBC  1-6C
97. TFR work up  first check for clerical errors
98. RhIg administered  prevent fetal cells from sensitizing mom
99. Computer crossmatch is acceptable if  no history and Ab screen is negative
100. Know Fisher-Race and Weiner nomenclature
101. O+ patient with no reaction at IS has 1+ at AHG. Auto is 1+  likely warm autoantibody
102. Type AB  Reaction with Anti-A/B, no reaction with A/B cell
103. AB blood type  Reaction with Anti-A/B/AB
104. TF reaction work up  clerical checks for errors and mix up of ABO incompatibility
105. Increases concentration of platelet concentrate  centrifuge at lo speed, remove plasma, hi speed
106. Immunohematologists  blood group antigens, histocompatibility antigens, autoantigens
107. If CC is negative  repeat the procedure with new reagent and check washer
108. When making aliquots and there is a breach in tubing  expiration date of the unit is now 24hrs
109. Can an autologous donor donate?  Only when time exceeds 72 between donation/surgery
110. RBC product to prevent TFR-GVH  Irradiated RBC
111. Dolichos bifloris  Anti-A1
112. Kleinhauer-Betke  divide fetal bleed by 30, round, then add 1
113. Decreased in platelets after transfusion  PTP
114. For serologic crossmatch to be omitted  Ab screen is negative and there is no history of Ab
115. HLA matching  used for organ transplants
116. QC testing of donor platelets found  21 CFR 640.25 Platelets – General Requirements
117. For kidney transplants  ABO type is the most important factor
118. Storage temperature of whole blood  4C
119. When shown signs of fainting or syncope  apply a cold compress to the back of neck
120. If parent are group A and B  possible offspring can be A/B/AB/O
121. neonatal alloimmune TC-penia  destruction of neonate platelets by mom’s alloantibodies
122. First step of suspected TFR  step the transfusion but keep IV line open with saline
123. Associated with TF of patient lacking IgA  anaphylaxis
124. When a pack of RBC’s are split in an open system  unit expires in 24hrs
125. HLA antibodies responsible for  TRALI
126. Bombay anti-H  from Ulex europaeus
127. A person previously with a hemophiliac can donate  if last sexual contact was more than 1 year
128. Febrile NHTR increate of >1C temperature about 37C during transfusion
129. Most common cause of severe HDFN  Anti-D
130. Which is acceptable to be returned to inventory  temperature-controlled for 2 hours
131. For a 450-500mL unite  63mL of anticoagulant-preservative is used
132. Storage for FFP  -20C
133. Interval between whole blood donation  8 weeks
134. Autologous blood  tests for ABO, Rh
135. Dura mater transplant donors are permanently deferred due to  CJD vCJD
136. Positive DAT in newborn  HDFN
137. Plasma frozen within 8 hours  retain Factor VIII
CHEMISTRY (17-22%):
1. Hemoglobin Synthesis  ALA synthase, PBG synthase, protoporphyrinogen oxidase, ferrochelatase
2. Reducing sugars  anomeric C/aldehydes free [lactose, glucose, ribose’
3. 17-ketosteroid production  measures androgen production
4. Increased serum osmolarity  diabetes insipidus
5. Aldoses  sugars with terminal carbonyl group (aldehyde)
6. Hb AS  hald Hb S half A
7. Insulin  responsible for glucose entry into cell
8. GGT function  transfers GG peptides, AA, water, other peptides
9. Elevation in LD-1 vs LD-2  AMI (LD flip)
10. Respiratory acidosis  inc pCO2 and acidosis
11. Pancreas hormones  lipase and amylase
12. LDL  total cholesterol – HDL – TG/5
13. When collecting ethanol sample  avoid alcohol wipes
14. Haptoglobin  decreases when IV hemolysis
15. Hepatic disease evaluation  ALT/SGPT
16. Tumor markers  CEA(colon), PSA(prostate), b-hCG(testes), AFP(liver)
17. A1C  measures average glucose levels over 2-3 months
18. Costisol  diurnal, higher at daytime
19. Coenzyme for LD for conversion of lactate to pyruvate  NAD+
20. Renal function panel  Glucose BUN, Creatinine, Na, K, Cl, CL, CO2, Ca, Albumin, P
21. Hepatic Function Panel  ASP, ALT, ALP, TP, Albumin, Total bili, Direct bili
22. Electrolyte panel  K, Na, Cl, CO2
23. Lipid panel  Cholesterol, lipoprotein, HDL, TG
24. Transferrin  decreased during APT
25. Valpro  administered roally
26. Vitamin A  transported by retinol binding protein
27. Peak digoxin  8-10 hours after oral dose (for CHF)
28. Aminoglycoside half life  2-3 hours
29. End product of bilirubin catabolism  urobilinogen
30. Tyrosine  catecholamine and thyroid hormone precursor
31. Creatinine clearance  (UV/P)* 1.73/SA = 72mL/min/m2
32. Exchange mechamism in RBC  chloride and decarbonate
33. Hemoglobin  8 ALA
34. Thrapeutic Drug monitoring  perform in heparin tube
35. Chylomicrons  formed by TG
36. Metabolic alkalosis  elevated pH, inc bicarbonate, normal PCO2
37. Treatment for COPD and athsma  theophylline
38. Alipoproteins  essential for lipid metabolism
39. Isoelectric point  when pH below, protein will be positively charged and move to cathode
40. Cyclospoirine elvels  measured with whole blood
41. Diabetes  Mellitus (fasting >126mg/dL, post-prandial >200mg/dL)
42. Wilson’s disease  decreased serum copper, low plasma ceruloplasmin
43. Centrifugation delay: Increased (K, ALT, AST, creatitine)
44. Centrigue delay: Decreased (Glucose, Ionized Ca, Bicarb, Folate)
45. Pernicious anemia  from lack of IF, cobalamin deficiency
46. Hemoglobin electrophoresis  separated by electrical charges
47. NaF  inhibits glycolysis
48. CYP450  able to make compounds more water soluble and enhance excretion
49. Uric acid  gout
50. Vitamin def  A(blindness), E(hemolytic acemia, RBC frag, D(rickett’s/osteomalacia), K(hemorrhage)
51. Hemolysis  increase K, Mg, Iron, TP
52. Marasmus  calorie deprivation (Kwashiokor is protein deprivation)
53. Diabetes  HbA1C>6.5^, FPG>126mg/dL, GTT>200mg/dL (sheen over 45 every 3 years)
54. Glucose  in whole blood is 11% lower than in plasma
55. Macroamylasemia  inc serum amylase and N/low urine amylase
56. NHLBI/AHA metabolic syndrome  FBG, TG, HDL-C, waistline, high BP
57. Down’s syndrome  assessed by hCG, inhA, AFP
58. Hemiacetyl  carbonyl and alcohol group
59. LD polypeptides  LD2(HHHM), LD3(HHMM), LD4(HMMM), LD5( MMMM)
60. Blood buffer  from bicarbonate and chloride
61. Immunoassay for hCG  tests for the beta subunit of hCG
62. Acute phase protein  A1A, CRP, Fibrinogen
63. Elevation of CK  DMD, CV accident, or exercise
64. Cutaneous porphyria  porphyria cutanea tarda, (congenital) erythropoetic proto/poryphia
MICROBIOLOGY [[[internally screaming]]] (17-22%):
Preanalytic Procedures:
1. Specimen Collection/Transport:
a. Malasezzia furfur  laid in EVOO
b. Haemophilus  need to be grown on chocolate, not SBA!
c. Acridium orange  AO powder + Na acetate buffer, determines bacteria in smears
d. OK for anaerobes recovery  swabs from deep sub-cuts, needle asp (ana-E-swab), Syringe asp
e. C. dificile culture  needs CCFA, culture is forever, doesn’t differentiate
f. Protozoal parasites that do not produce disease  commensal
g. Coccidioies immitis  cobweb mycelium, irregular sized spherules into tissue
h. Cyst lacking chromatin  E. nana and I. bustchlii
i. Scistosoma mansoni  lateral spine, causes bilharziasis
j. Microsporum auduoinii  Wood’s lamp florescence from tinea ciptis
k. Vibrio cholerae  gray-yellow colonies, curved G- bacteria
l. Pinworm  30x5-um with flattened bean egg
m. Gardnerella vaginalis  HBT agar
n. Fusarium  macroconidia banana shaped, orange/rose color
o. Capnocytophagia ocharcea  gingivitis fingerlike projections
p. KOH prep  fungal elementa (A. fumigatus)
q. Bordatella pertussis  Bordet gengou
r. Protoxoa  stained by trichrome
s. Enterobact  G- bacilli, glu ferm, motile (exc KSY), CTC ox (exc ples), nitrai (ex photo/zeno
t. Anaerobis panel  SBA, chocolate, MacConkey (not CNA)
u. Kinyoun acid fast  mycobacteria via mycolic acids
v. Indicators  MAC(neutral red), XLD(phenol red), EMC(myosin Y), HE(BB)

IMMUNOLOGY (5-10%):
1. Zones  Prozone(Ab excess) and Postzone (Ag excess)
2. Innate immunity  skin, mucus membranes
3. Vaccination of HBV  HBsAg-, Anti-HBc-, anti-Hbs+
4. Breast cancer  tumor markers of estrogen/progesterone receptors
5. Light chains  kappa and lambda
6. RPR syphilis tests FP  caused by infectious mononucleosis
7. ANA  SLE, speckled (with high titer)/homo// CREST: speckled, Scleroderma: nucleolar, Sjogren: peri
8. IgG  half life of 20days, binds with neonatal Fc
9. AIDS  decrease in CD4
10. Flow cytometry  HIV, leukemia, lymphoma
11. MHC  1(HLA-A/B/C, CD8), II(HLA-DR/DP/DQ CD4), III (complement/cytokines)
12. TORCH panel  T. gondii, Other viruses, Rubella, CMV, Herpes
13. Syphilis confirmatory  FTA-ABS
14. Humoral immunity  antibody production
15. Treponemes  darkfield microscopy
16. Hapten  nonimmune material that can elicit immune response when bound to carrier protein
17. Cytokines from activated T-cells  IL-2, 3
18. Representative assays in trepenomal methods  Chemiluniescent, ELISA, FTA-ABS
19. Syphilis stages  1(chancre, contagious), 2 (rash), latent (non-symptomatic), 3 (destruction)
20. Central tolerance  cloncal eletion (T-cells) and editing (B-cells)
21. Immunogenic  proteins, carbs, lipids
22. PPD testing  targeted tuberculin testing
23. Activation unite in classical complement  C4/2/3
24. SCID  reduction/dusfunction or T-cell, B-cell, NK
25. Monoclonal antibody production  fusion of Ab specific lymphocute and myeloma cell
26. Best diagnosis for RMSF  IFA testing
27. Cytokines  soluble protein that regulated immune response
28. Second line of defense  phagocytic cells, complement
29. Sepsis  inc HR, leukocytosis, inc temperature
30. Blood specimen collection for Ab conc of infectious diseases  2 weeks apart
31. H50  CH50 (classic, 50%RBC lysis) and AH50(alternative) ) pathways
32. For FANA testing  may demonstre anti-mito Ab in primary biliary cytosis
33. SLE  positive ANA, circulating immune complexes, increased ESR, dec complement
34. Tuberculin skin test  read after 48-72
35. Binds IgE antibodies  basophil
36. PCR hybridization  comp bases link (H-bond), annealing, ssNA ds, can happen between D/RNA
37. Risk factor GVHD  source of immunocomp lymphs, HLA differences, inability to reject donor lymph
38. CA-125  ovarian cancer (CA15-4/27-29 is breat cancer)
39. CEA  fetal, colorectal, lung, breast, GI tumors
40. Specific allergens  RAST
41. Vaccine types non-experimental  live attenuates, inactivated, toxoid (Experimental, RV)
42. Gaucher’s disease  monocyte-macrophage
43. CD5 antigen  from mature T cells
44. HepB timeline: HBsAg  HBeAg  anti-HBe  anti-HbC
45. HepB: Vaccine (anti-HbS only), Infection (HBs/cAg) and anti-Hbc
46. Hep B markers  HBc(exposure), HBs(infection)
47. Graft rejection  actue (7-21d), hyperacute(mins), accelerated(2-5d), chronic(3mo)
48. Bruton’s agammaglobulinemia  congenital B-cell disorder
49. Effector lymphs  (TH2 regulates Ab) (TH1 regulates IFM) (CD8 destroys viral)
50. Real time PCR  microbe ID, genotype of HLA, ID DNA sequences,
51. Purpose of C3/5a and split products  inc vasc permeability, smooth muscle contraction, histamine rel
52. Screening for retroviruses  Ab to HIV1/2, HTLV1/2, NA for HIV-1 RNA
53. Disorders of primary immunodeficiency  B-cell disorders
LAB OPS (5-10%):
1. Reasons failed internal control for qPCR  sample high load, not adding IC to MM, amp not occurring
2. Blood cultures  volume important, do not draw >1 from same site, iodine prep
3. Coefficient of Variation  (STDEV/mean)*100
4. Lab supervisor duties  tech duties, admin duties of director, overseeing operations
5. Procedure to monitor precision of assay  run duplicate samples
6. Low/high controls run for 30 days  determines precision and acceptable range
7. rtPCR graph needed for absolute quantification  standard curve
8. Steps in NGS  template prep, amplification, sequencing, data analysis, imaging
9. Unsatisfactory specimens  hemolysis, insufficient volume, improper ID
10. Consider for workspace  contamination error, steps in different spaces, amplicon contamination
11. Laboratory acquired bacterial infection  Brucella species
12. Increase from delay  K, ALT, AST, creatinine
13. Decrease from delay  glucose, ionized Ca, bicarbonate, folate
14. Time to clot before centrifuge  20 minutes
15. Westergard rules  22S (both controls exceed 2SD, twice in succession) 13S (1 of 2 QC is >3SD), R4s
(range of controls >4SD), 41S (4 results >1SD on same side can be both controls), 10x(same side)
16. Draw tube order  Sodium citrate, Serum, Heparin, EDTA, NaF/Oxalate
17. Common in both RNA/DNA  sugar, PO4 residue, base
18. Majority of analytical errors  preanalytic
19. LRN sentinel labs  rule out critical biological agents or send to reference
20. Analyzer  RA(OOS), discrete(own space), parallel(all done same ), multi-channel (multiple analysis)
21. ePHI media  records on hospital server HD
22. College coursework and rotation for Bachelor’s  hospital-based MLS/CLS
23. Monitors  20-40 inches away from eyes
24. Gaussian  1SD (67%), 2SD(95%), 3SD(99.7%)
25. Glander’s disease  Burkholderia mallei
26. Violation of billing requirements  perform testing on verbal order of nursing assistant
27. Route of transmission for BF/HIV  blood, CSF, pleural fluid
28. Over budget  (actual-budget)/budgeted *100
29. PCR with failed internal control but positive result  report as positive (IC for TN)
30. Well-designed rating scale  speace for not observed
31. Bioterrorism agents  A>B>C
32. Workload reporting system  helps in plan, develop, maintain lab services with admin/budget control
33. Performance evaluation  from standard, description, and reward
34. Dilution factor in series  product of tube n dilution factor
35. Health care workers with BF contact  offered vaccine for Hep B
36. Risk for transmission of BB pathogens  bloody urine, semen, pleural fluid, sex, needles
37. Lyophilization  freezedrying of bacteria
38. Specimen with no additive should clot  min 30 min, max two hours prior to centrifugation
39. Meters  osmometer(VP), fluorometer (excitation emission), nephelometer(light scatter),
spectrophotometer (light at WL), coulometer (electricity between electrodes)
40. Mercury chloride with KCl  saturated calomel
41. When frozen to live wire  use non-conductive material to separate
42. Objective tests  limited because they only measure cognitive abilities
43. LIS  hardware and software to manage data in lab
44. Taq polymerase  70C
45. OK pneumatics  Alb, ALP, AST, Cl, creatinine, Glucose, Na, Bili, Protein, BuN, UA, TT, WBC
46. Labelled with biohazard  container for needle disposal (blood contact)
47. Microscope  (stage # um *1000)/ ocular um units
48. When 2 consecutive controls are greater than 2SD  recalibrate and releate controls
49. Detection of translocation  break-apart probes
50. Lab infection control plan  goals for surveillance, system to ID infected patients, trained personnel
51. Exposure to TB tested by  TST
52. To report a positive rtPCR sample  sample crosses threshold and peaks within target temp
53. Osmolarity (G/BUN/Na)  2Na + (G/18) + (BUN/2.8)
54. % recovery  (spiked-baseline)/concentration added *100
55. Lean definition for waiting  dependency on other to complete a task before starting task
56. Root Cause Analysis  Collect info, ID reasons, Chart factors, Generate recommendations
57. DMAIC  define, measure (map and analyze current processes), analyze, implement, control
58. Minimum specific resistance for Type I water systems 10.0 (II is 2.0, III is 0.1)
59. Taxonomy  Affective (commitment), cognitive (problem solving), psychomotor(adaptation)
60. Routine phlebotomy sites  antecubital, cephalic, basilic
61. CLIA 1988  2 controls daily for most methods
62. Phlebotomist requires  2 patient ID, did not explain/inform patient, label in presence
63. Large DNA fragments >50kb  use pulsed field electrophoresis
64. Normality  find moles per L *valence
65. Parameter to compare how close two different methods compare  coefficient of variation
66. Ideal disinfectant in lab  10% bleach
67. Types of fire  A (flammables), B (liquids), C(electric), D(combustion)
68. +/- Controls: Indole (E. coli vs. K. pneumonia), b-hemolysis (S. aureus vs. S. pneumoniae), Catalase (S.
aureus vs. S. pyogenes), H2S (P mirabilis and S. typhi vs. E. coli)
69. Radiation source in AAS  hollow cathode lamp
70. NA amplication techniques  target ampl and signal amp
71. Syphilis  observe under dark field
72. Analytical  specificity (exclusive analyte), sensitivie (change in analyte), range/LoD
73. End Analyzers  Back-end (removal of specimens to storage, disposal, aliquoting), front (ID/label)
74. FISH  direct NA test using RNA northern or DNA southern to detect variations
75. Exposure with greatest risk of HIV  percutabeous injury
76. Electroosmosis  motion of liquid when voltage us applied
77. Trends  results on one side of mean constantly inc/dec
78. Shift  consistent values on one side of mean
79. T-test  comparing two means from matched groups
80. Crying  increases WBC in babies
81. QC cost per test  [[(QC test cost * times per day) *365] + [monthly *12]]/tests done per year
82. Normality  %*10/eq wt[which is mol wt/pos valence]
83. Full-time equivalents  total of productive and non-productive
84. Exposure Control Plan  procedures for handling medical waste
85. Chemical Hygiene Plan  ID chemicals and label and record
86. Hazard Communication Standard  outlines hazard classification and labeling
87. SDS  info about chemicals in library
88. Value steam mapping  document/analyze steps of test to customer
89. Light-blue collection  if use of butterfly, always deaw the waste tube
90. If sample negative and IC is negative  repeat the sample
91. Minimum from possible bioterrorism agents/aerosols  Class II BSC used
92. Standard deviation  sqrt ((sum of square of differences/[#-1])
93. Dermal puncture for capillary blood specimens  ring or middle finger
94. CFR regulations  minimum standards a facility can exceed
95. Freezing point depression  lowered proportional to paricles in solution
96. FMEA  evaluated to analyze risk and highlight aspects for improvement
97. For PPMP  limited to bright-field or phase contsdy semen analysis)
98. dPCR  best to evaluate SNP
99. Normal densiometric PE  albumin band first and largest
URINALYSIS (5-10%):
1. Crystals  Basic pH (Amorph PO4, Amm Biurates, Triple PO4, Ca carbonate, Ca PO4)
2. Crystals  Acid pH (Uric acid, Amorphous/Acid/Sodium urates, Ca oxalates)
3. Acid urine  meat diet, cranberries, high urine glucose, ketoacidosis, diarrhea, starvation, emphysema
4. Basic urine  Meta alkalosis, veggies , kidney failure, UTI, hypervent, R tubular acidosis, old, bacteria
5. BJ Protein Heat Precipitation  Precipitates at 40-60C, Re-dissolves at 100C
6. NRBC  look like fried eggs, dark purple yolk and light purple cytoplasm
7. Myoglobinuria  present in massive muscle trauma
8. Functions of CSF  supply nutrients to NS tissue, protect spinal cord, remove waste from cerebral
9. Routine sperm count  1:20
10. Normal range of urine pH  4.5 to 8
11. Most cerebrospinal fluid is produced  choroid plexus
12. Fluid found in cavity surrounding the lungs  pleural fluid
13. Requires 72 hour stool collection  quantitative fecal fat
14. Increased levels of urine protein can be an early indicator  renal disease
15. Abnormally low sperm concentration  5x10^6 sperm/mL [N=10-20x10^6]
16. Glucose levels in CSF  About 2/3rds blood glucose
17. Tamm-Horsfall protein  hyaline distal casts, produced by/coats/lubricates tubules
18. Yellowish CSF  Xanthochromia
19. Storing/handle of strips  compare with color chart, handle at ends, store at RT
20. Viscosity of synovial fluid is from mucopolysaccharide  hyaluronic acid
21. Urine  should not be centrifuged, must be well-mixed, tested within 2h, at RT
22. Glucosuria  diabetes mellitus, impaired tubular reabsorption/AKF, Fanconi’s
23. Neural tube defects detected  by alpha-fetoprotein
24. Fruity urine odor  from starvation, malabsorption, diabetes mellitus
25. CSF with lymphocytes  viral meningitis
26. QC on strips  as often as needed, on each new lot, when new bottle is opened, when questioned
27. RBC, WBC, proteinuria, casts  formed by acute glomerulonephritis
28. Counted cells on CSF >100  make larger dilution
29. Ketone component measured by nitroprusside  acetoacetic
30. Cystinuria  hexagonal crystals in urine
31. Negative GO test and positive reducing sugars  presence of non-glucose reducing sugar
32. Normal casts from exercise  hyaline and granular casts
33. Yellowish CSF  xanthochromia
34. Clinitest  tests for all reducing substances
35. Tyrosine crystals  look like needles
36. Xanthochromic  can be pale orange, pink, yellow
37. CSF used for hematology counts  #3 (1st is for chem/immune, 2nd is micro, 3rd is hematology)
38. FP in bilirubin result  large doses of chloropromazine/Thorazine
39. Casts found in acute pyelonephritis  WBC casts
40. To distinguish RBC, oil drops, yeast  add acetic acid to lyse RBC
41. Xanthocromic in CSF  from hemorrhage
42. Erich-aldehyde reaction  urobilinogen
43. Strip protein tests for mainly  albumin
44. For UTI’s, leukocyte esterase should be evaluated with  nitrite
45. Specific gravity  on strip measured by relationship between ionic concentration and SG
46. Cell with two pink nuclei and light purple abundant cytoplasm  mesothelial cell
47. Crystals that look like rupees  uric acid
48. Nitrite can be used to  monitor AB therapy, detect bladder infection, screen for recurrent infection
49. Confirmation of positive protein from dipstick  Sulfosalicylic acid
50. Diabetic woman with high protein and foamy urine  large albumin concentration
51. Associated with acidic urinary pH  high urine glucose
52. India Ink prep  detect cryptococcus neoformans
53. Recommended method for CSF sample  cytocentrifugation
54. Which causes hematuria and positive blood on strip  glomerulonephritis
55. Clinitest  based on reduction of Copper
56. Confirmatory for urobilinogen  Watson-Schwartz test
57. RBC found in urine  hematuria
58. Glitter cells  PMN
59. Storage of urine samples  store at 4C for 24hrs
60. Positive leukocyte esterase  PMN, basophils, eosinophils (granulocytes)
61. Nephrotic syndrome  oval fat bodies, fatty/waxy casts, renal tubular epithelial cells
62. L/S ration in amniotic fluid assesses  respiratory distress syndrome
63. Strenuous exercise  hyaline casts
64. Protein used to monitor BBB  albumin
65. CSF cell with frilly edges  ependymal/choroid plexus cell
66. Ribbon-like stools  bowel obstruction
67. Kidney functions  acid-base balance, retains nutrients/water, blood filtration
68. WBC count  (# counted * dilution) / #squares*0.1
69. CSF lymphocytosis  from viral/fungal/tuberculous meningitis
70. Sudan III detects  fat
71. In urine, similar size to RBC  yeast
72. Strip handling  compare with chart, handle at ends, store at RT
73. Albuminemia testing  to detect albumin before there is severe renal damage
74. Infant’s negative specimen of glucose  next is to do Clinitest for other reducing substances
75. LE positive test of WBC  PMN, eosinophils, basophils
76. Infective mono  reactive lymphocyte
77. Indicative of kidney disease  renal tubular epithelial cells
78. Testing of urine for poryphyrins  urine stored in dark/foil container
79. CSF meningitis  viral (inc protein), bacterial (dec glucose, inc protein), fungal (N glucose, protein)
80. Large foamy cells in CSF  synovial lining cells
81. When not immediately tested, semen  stored at 37C
82. Sperm motility  Progressive (32%), Total (40%)
83. Normal urine production over 24hr  700ml to 1700ml/24hr
84. Glomerular filtration assessment  creatining clearance (urine conc * volume) / plasma conc
85. Associated with acut pyelonephritis  WBC casts
86. Functions of kidney  exocrine (eliminate waste products), endocrine (hormones, BP, RBC product)
87. High protein in urine  blood in urine, alkaline medication, high bilirubin
88. Prominent vacuolizarion of abnormal lymph cells  Burkitt’s lymphoma
89. CSF collection  L3-4
90. DCT function  maintain water electrolyte balance and acid-base balance
91. Fluid deprivagtion for 12hrs  >800mIsm
92. Nephrotic syndrome  associated with edema, dec serum albumin, inc proteinuria
93. Urine for centrifugation of microscopic exam  10-15mL
94. Lower reference for semen volume  1.5mL (N is 2-5mL)
95. Not detected in Acetest  B-hydroxy butyric acid
96. Amount of adult CSF  90-150mL
97. Nitrates reduced to nitrites by  gram negative bacteria
98. Functions of kidney  glomerulus (filtration) PCT (water reabsorption), DCT (ion pH/electro balance)
99. CSF dilutions: slight hazy(10), hazy (20), cloudy (100), cloudy/slight blood (200), blood (10000)
100. Bacterial urine contramination  more alkaline urine

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy